Items tagged with Access

Activists: Call on your countries to use bedaquiline-based regimens to treat TB (post)

The Global Coalition of TB Activists (GCTA), Treatment Action Group (TAG) and the DR-TB Scale-Up Treatment Action Team (DR-TB STAT) developed a letter template to help activists call for bedaquiline-based, injectable-free regimens for the treatment of drug-resistant TB in their countries.

Call for applications: IP and access to medicines course 2018 (post)

Having pro-health intellectual property (IP) laws ensures access to essential medicines.

Public health experts discuss importance of implementing guidelines, improving access to treatment for MDR-TB (post)

UN exempts humanitarian items to North Korea from sanctions (post)

SEOUL, Nov. 9 (UPI) -- The United Nations has allowed shipment of humanitarian supplies to North Korea, including medical equipment, for a healthcare project.

Experts fear a TB epidemic in North Korea amid a crucial medication shortage (post)

(SEOUL) — The withdrawal of a major international aid organization threatens to leave tens of thousands of tuberculosis patients in North Korea without the medication they need and could spiral into a severe crisis if it is not addressed soon, according to health experts familiar with the situation in the North.

India: 400 MDR-TB patients in 7 states to get crucial drug (post)

India gets doses of Delamanid from USAID.

2018 Access to Medicine Index (post)

The 2018 Access to Medicine Index finds that a handful of pharmaceutical companies are developing the bulk of urgently needed new medicines for the poor.

FIND establishes “Voices for Diagnosis” annual prize to recognize and enable innovative approaches that improve diagnostic access in low- and middle-income countries (post)

-- The Voices for Diagnosis annual prize is open to patient groups as well as health and rights advocacy organizations, acknowledging the key role of communities in promoting diagnostic access
-- In 2018/19, three awards of US$10,000 each – contributed by FIND; BD, Inc; and Johnson & Johnson – will be made to recognize and support initiatives that encourage appropriate antibiotic use and fight antimicrobial resistance
-- The prize will be adjudicated and supported by the Diagnostics Ambassadors, an informal network of thought leaders from diverse disciplines who help champion the important role played by diagnostics in global health

TB Alliance receives GHTC Partnership Award for development of child-friendly TB medicines (post)

[November 28, 2018, WASHINGTON, D.C.] – TB Alliance and partners were honored today as the winner of the Global Health Technologies Coalition (GHTC) 2018 Innovating for Impact Partnership Award, for the development of improved child-friendly tuberculosis (TB) medicines. Since the improved medicines were introduced in 2016, 85 countries have procured more than 800,000 treatment courses. Appropriately-dosed and palatable, these new medicines are improving TB treatment and survival for the estimated one million children stricken with TB each year.

Countries in eastern Europe and central Asia agree to expand access to a range of medicines (post)

On 22 November, at a meeting held in Minsk, Belarus, countries from across eastern Europe and central Asia signed the Statement on Expanding Access to Affordable and Quality Assured Medicines and Diagnostic Technologies for HIV, Tuberculosis and Viral Hepatitis (Minsk 2).